Top Stories Novo Nordisk Stock Surges on Half-Price Ozempic Deal, FDA Approval BREAKING: Novo Nordisk’s stock is surging following a 50% discount on its popular weight-loss drug, Ozempic. This urgent development comes as the Danish pharmaceutical... Editorial18 August, 2025
Top Stories FDA Approves Wegovy for Liver Disease, Novo Nordisk Shares Surge URGENT UPDATE: The U.S. Food and Drug Administration (FDA) has just approved Wegovy for an additional use in treating a specific form of liver... Editorial18 August, 2025